logo-loader

Midatech Pharma PLC

Receive alerts
Market:
AIM
Market Cap:
£16.21 m
Price
3.45 GBX
Change
-5.48%
52 weeks high
12.74
52 weeks low
2.45

In brief

Midatech is fully focussed on enhancing and extending the lives of patients with rare and serious cancers. We have built an organization distinguished by world-class scientists with a talent for developing and applying our novel drug delivery technologies to improve existing, or develop new, treatments for these diseases. Our driving  philosophy is to seize scientific and clinical opportunities and invest in programmes and partnerships to get these treatments to approval and commercialisation.

Deep dive We explore the investor case for growth companies

Snapshot

  • Now a pure-play R&D company 
  • Has three breakthrough technologies 
  • Two drugs in clinical trials